Reconsideration of subarachnoid hemorrhage
10.3760/cma.j.issn.1006-7876.2019.12.002
- VernacularTitle: 谈谈对蛛网膜下腔出血的再认识
- Author:
Chao QIN
1
;
Chuanqiang PU
2
Author Information
1. Department of Neurology, the First Affiliated Hospital of Guangxi Medical University, Guangxi Key Laboratory of Precision Medicine for Prophylaxis and Treatment of Cardiovascular and Cerebrovascular Diseases, Nanning 530021, China
2. Department of Neurology, People′s Liberation Army General Hospital, Beijing 100853, China
- Publication Type:Editorial
- Keywords:
Subarachnoid hemorrhage;
Aneurysms;
Neuroimaging;
Radiography, interventional;
Intensive care
- From:
Chinese Journal of Neurology
2019;52(12):989-993
- CountryChina
- Language:Chinese
-
Abstract:
Subarachnoid hemorrhage (SAH) is a common hemorrhagic cerebrovascular disease, which not only has devastating impact on the central nervous system but also on many other organs. Due to the differences in the age of onset, etiology, risk factor, original bleeding site and amount of bleeding, complication, and the level of medical center, the clinical outcomes for specific patients are quite different. With the progress of medical science, the further development of neuroimaging, neurointervention and neurological intensive care has significantly improved the overall clinical outcome of SAH and greatly reduced the mortality rate. In particular, the results of some high-quality multicenter randomized controlled trials have been published in recent years, which provide new evidence-based evidence for SAH risk assessment and treatment selection. This article focuses on the etiology, emergency diagnosis and clinical evaluation, treatment of common causes and treatment of severe neurological diseases of SAH, so as to improve the understanding of SAH and guide clinical practice.
